Respiratory Verification Panel 2 (21 x 0.25mL) (EA)

ZeptoMetrix external quality controls, and verification panels have demonstrated performance on a variety of molecular platforms. Based upon the platform and assay’s product configuration, including but not limited to fill volumes and concentrations of analytes, we recommend our ZeptoMetrix Respiratory Verification Panel 2 to be used in conjunction with the QIAGEN® QIAstat-Dx® system.

NATtrol Respiratory Verification Panel 2 includes 20 targets: Adenovirus 3, B. pertussis strain A639, C. pneumoniae strain CWL-029, Coronavirus 229E, Coronavirus HKU-1 Recombinant, Coronavirus NL63, Coronavirus OC43, Influenza A H1N1pdm strain A/NY/02/09, Influenza A H1N1 strain A/New Caledonia/20/99, Influenza A H3N2 strain A/Brisbane/10/07, Influenza B strain B/Panama/45/90, M. pneumoniae strain M129, Metapneumovirus 8 strain Peru6-2003, Parainfluenza virus Type 1, Parainfluenza virus Type 2, Parainfluenza virus Type 3, Parainfluenza virus Type 4, Rhinovirus 1A, Respiratory Syncytial Virus (RSV) A, and SARS-Related Coronavirus 2 (SARS-CoV-2) strain USA-WA1/2020.

• Formulated with purified, intact organisms
• Organisms are chemically modified to render them noninfectious
• Refrigerator stable—store between 2 and 8°C
• sodium azide
• 20 x 0.25 mL vials of bacterial, fungal, or viral targets and 1 x 0.25 mL vial of negative control

NATtrol products are ready-to-use, inactivated full process controls designed to evaluate the performance of molecular tests. They can be used for verification of assays, training of laboratory personnel, and monitoring assay-kit lot performance. NATtrol products contain intact organisms and should be run in a manner similar to clinical specimens.

• ENGLISH (PI)
• ENGLISH (SDS)

For Research Use Only. Not for use in diagnostic procedures. Quality control materials should be used in accordance with local, state, federal, and accreditation requirements. This product is not intended to replace the manufacturer's controls provided with the assay. Propagation or commercialization are prohibited without prior written consent from Antylia Scientific.

When used as a control for nucleic acid tests, the same protocols as those used to amplify extracted clinical specimens should be employed.

The suitability and performance characteristics should be determined by your laboratory for each intended usage.